Allievex (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 23, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2019
- Founders
- Pappas Capital
- Company Description
- Allievex is a clinical-stage biotechnology company developing novel therapies for the treatment of rare pediatric neurodegenerative diseases. Its lead product candidate is tralesinidase alfa, an investigational enzyme replacement therapy for children with Sanfilippo syndrome type B or mucopolysaccharidosis IIIB (MPS IIIB).
- Market
- Rare pediatric neurodegenerative diseases
- Location
- Marblehead, MA, USA
- Coinvestors
- Novo Holdings, Pappas Capital